インフルエンザ:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Influenza Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Influenza 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Influenza 24
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Influenza Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Sanofi 56
Clinical Trial Overview of Sanofi 56
MedImmune, LLC 61
Clinical Trial Overview of MedImmune, LLC 61
F. Hoffmann-La Roche Ltd. 65
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 65
CSL Limited 67
Clinical Trial Overview of CSL Limited 67
Baxter International Inc. 69
Clinical Trial Overview of Baxter International Inc. 69
Daiichi Sankyo Company, Limited 71
Clinical Trial Overview of Daiichi Sankyo Company, Limited 71
Crucell Holland B.V 72
Clinical Trial Overview of Crucell Holland B.V 72
BioCryst Pharmaceuticals, Inc. 73
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 73
Adimmune Corporation 74
Clinical Trial Overview of Adimmune Corporation 74
Sinovac Biotech Co., Ltd. 75
Clinical Trial Overview of Sinovac Biotech Co., Ltd. 75
OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Clinical Trial Overview of OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd. 76
Novartis Vaccines and Diagnostics, Inc. 77
Clinical Trial Overview of Novartis Vaccines and Diagnostics, Inc. 77
Novavax, Inc. 78
Clinical Trial Overview of Novavax, Inc. 78
VaxInnate Corporation 79
Clinical Trial Overview of VaxInnate Corporation 79
Protein Sciences Corporation 80
Clinical Trial Overview of Protein Sciences Corporation 80
Abbott Laboratories 81
Clinical Trial Overview of Abbott Laboratories 81
Kaketsuken K.K. 82
Clinical Trial Overview of Kaketsuken K.K. 82
Pfizer Inc. 83
Clinical Trial Overview of Pfizer Inc. 83
Clinical Trial Overview of Top Institutes / Government 84
The National Institute of Allergy and Infectious Diseases 84
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 84
The University of Hong Kong 91
Clinical Trial Overview of The University of Hong Kong 91
University of Oxford 92
Clinical Trial Overview of University of Oxford 92
University Hospitals of Leicester NHS Trust 93
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 93
National Hospital Organization Mie National Hospital 94
Clinical Trial Overview of National Hospital Organization Mie National Hospital 94
Centers for Disease Control and Prevention 95
Clinical Trial Overview of Centers for Disease Control and Prevention 95
St. Jude Children’s Research Hospital, Inc. 96
Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc. 96
The University of British Columbia 97
Clinical Trial Overview of The University of British Columbia 97
University of the Witwatersrand 98
Clinical Trial Overview of University of the Witwatersrand 98
Program for Appropriate Technology in Health 99
Clinical Trial Overview of Program for Appropriate Technology in Health 99
University of Rochester 100
Clinical Trial Overview of University of Rochester 100
Columbia University 101
Clinical Trial Overview of Columbia University 101
Assistance Publique – Hopitaux de Paris 102
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 102
McMaster University 103
Clinical Trial Overview of McMaster University 103
Institut National de la Sante et de la Recherche Medicale 104
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 104
Queen Mary Hospital 105
Clinical Trial Overview of Queen Mary Hospital 105
University of Pittsburgh 106
Clinical Trial Overview of University of Pittsburgh 106
Hadassah Medical Organization 107
Clinical Trial Overview of Hadassah Medical Organization 107
University of Michigan 108
Clinical Trial Overview of University of Michigan 108
University of Alberta 109
Clinical Trial Overview of University of Alberta 109
Five Key Clinical Profiles 110
Appendix 161
Abbreviations 161
Definitions 161
Research Methodology 162
Secondary Research 162
About GlobalData 163
Contact Us 163
Disclaimer 163
Source 164


【レポート販売概要】

■ タイトル:インフルエンザ:グローバル臨床試験レビューH2, 2013
■ 英文:Influenza Global Clinical Trials Review, H2, 2013
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162195
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。